The susceptibility to and the outcomes of COVID-19 are strongly associated with the presence of CV risk factors and with established CV disease. Clinical trials inve...

The novel coronavirus disease (COVID-19) pandemic has impacted global economies. These disruptions, also experienced by the global industry-sponsored research (ISR) ...

In the pharmaceutical industry, about one-third of all drugs in the pipeline of the top ten pharmaceutical companies were initially developed elsewhere. Sponsor comp...

Following the emergence of the novel coronavirus, more than 1000 clinical trials for non-COVID-19 indications were delayed, put on hold, or even postponed outright. ...

The pandemic has brought to the surface a host of long-standing challenges that the medical community at large is now seeking to address. Rosamund Round, Vice Presid...

Frontotemporal lobar degeneration (FTLD) encompasses a variety of clinical and genetic progressive neurodegenerative syndromes, which include the behavioural variant...

Licensing and decisions on public health use of a vaccine rely on a robust development program that permits a risk-benefit assessment of the product in the target po...

While each clinical trial currently re-invents the wheel, a carefully designed and regulatory compliant medicines app brings access to a ready-made, constantly updat...

Quality Management in clinical trials consists of strategic, efficient activities that are conducted to ensure that a trial is performed, and that trial data are gen...

COVID-19 has acted as something of a catalyst, encouraging increased Innovation, Technology adoption, and a willingness to embrace digital transformation. Shrishaila...